Drug intelligence / Profile preview

Nitro G

Development stage
Phase 4
Lead developer
Troikaa Pharmaceuticals
Modality
Small Molecules
Administration
Sublingual
01

Overview

Nitro G is a sublingual spray formulation of nitroglycerin (glyceryl trinitrate), a potent vasodilator used for the acute relief and prophylaxis of angina pectoris. It is designed for rapid absorption through the oral mucosa, allowing the active ingredient to bypass first-pass hepatic metabolism and enter the systemic circulation quickly. Nitroglycerin acts as a prodrug that is bioactivated by mitochondrial aldehyde dehydrogenase (ALDH2) to release nitric oxide (NO). The released nitric oxide then stimulates soluble guanylate cyclase (sGC), increasing the intracellular concentration of cyclic guanosine monophosphate (cGMP). This increase in cGMP activates protein kinase G, leading to the dephosphorylation of myosin light chains and the relaxation of vascular smooth muscle. The resulting systemic vasodilation primarily affects the venous system, reducing venous return (preload) and myocardial wall tension, which decreases myocardial oxygen demand and alleviates anginal pain.

Brand names
Nitro GNitro-G
Other names
nitroglyceringlyceryl trinitrate1,2,3-trinitroglycerolGTN
02

Targets

ALDH2 (Mitochondrial Aldehyde Dehydrogenase)sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on Nitro G.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitro G.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call